Investing.com - Corbus Pharmaceuticals Holding reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Corbus Pharmaceuticals Holding announced earnings per share of $-0.0700 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.0600 on revenue of $220K.
Corbus Pharmaceuticals Holding 's are down 41.36% and is trading at $0.1275 , still down 88.51% from its 52 week high of $1.11 set on Tuesday, November 16, 2021.
Corbus Pharmaceuticals Holding shares lost 1.92% to trade at $0.1275 in intra-day trade the report.
Corbus Pharmaceuticals Holding follows other major Healthcare sector earnings this month
Corbus Pharmaceuticals Holding's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar